The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1973, 111: 1407-1410.
Copyright © 1973 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porter, D. D.
Right arrow Articles by Cox, N. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Porter, D. D.
Right arrow Articles by Cox, N. A.

Failure to Demonstrate a Humoral Immune Response to Scrapie Infection in Mice1

David D. Porter, Helen G. Porter and Nancy A. Cox

From the Department of Pathology, University of California School of Medicine, Los Angeles, California 90024

Abstract

Although scrapie is clearly a transmissible disease caused by a small stable agent, previous conventional attempts to demonstrate humoral antibody have not met with success. In this study no evidence of humoral antibody to the scrapie agent was found in infected mice by regular or antiglobulin potentiated neutralization tests, indirect immunofluorescence tests employing various agent-containing targets, or by examining brains, spleens, and kidneys for the presence of immune complexes. The results suggest that scrapie infection is fundamentally different from slow or persistent virus infections in which humoral antibody may be demonstrated by the techniques used in this study.

Footnotes

1 This work was supported by Grant AI-09476 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Sacquin, A. S. Bergot, P. Aucouturier, and M. Bruley-Rosset
Contribution of Antibody and T Cell-Specific Responses to the Progression of 139A-Scrapie in C57BL/6 Mice Immunized with Prion Protein Peptides
J. Immunol., July 1, 2008; 181(1): 768 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. S. Spinner, R. B. Kascsak, G. LaFauci, H. C. Meeker, X. Ye, M. J. Flory, J. I. Kim, G. B. Schuller-Levis, W. R. Levis, T. Wisniewski, et al.
CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils
J. Leukoc. Biol., June 1, 2007; 81(6): 1374 - 1385.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. R Trevitt and J. Collinge
A systematic review of prion therapeutics in experimental models
Brain, September 1, 2006; 129(9): 2241 - 2265.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gregoire, A. S. Bergot, C. Feraudet, C. Carnaud, P. Aucouturier, and M. B. Rosset
The Murine B Cell Repertoire Is Severely Selected against Endogenous Cellular Prion Protein
J. Immunol., November 15, 2005; 175(10): 6443 - 6449.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Khalili-Shirazi, S. Quaratino, M. Londei, L. Summers, M. Tayebi, A. R. Clarke, S. H. Hawke, G. S. Jackson, and J. Collinge
Protein Conformation Significantly Influences Immune Responses to Prion Protein
J. Immunol., March 15, 2005; 174(6): 3256 - 3263.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Marella, C. Gaggioli, M. Batoz, M. Deckert, S. Tartare-Deckert, and J. Chabry
Pathological Prion Protein Exposure Switches on Neuronal Mitogen-activated Protein Kinase Pathway Resulting in Microglia Recruitment
J. Biol. Chem., January 14, 2005; 280(2): 1529 - 1534.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Gregoire, C. Logre, P. Metharom, E. Loing, J. Chomilier, M. B. Rosset, P. Aucouturier, and C. Carnaud
Identification of two immunogenic domains of the prion protein--PrP--which activate class II-restricted T cells and elicit antibody responses against the native molecule
J. Leukoc. Biol., July 1, 2004; 76(1): 125 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. B. Rosset, C. Ballerini, S. Gregoire, P. Metharom, C. Carnaud, and P. Aucouturier
Breaking Immune Tolerance to the Prion Protein Using Prion Protein Peptides Plus Oligodeoxynucleotide-CpG in Mice
J. Immunol., May 1, 2004; 172(9): 5168 - 5174.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. C. Bartz, J. M. Aiken, and R. A. Bessen
Delay in onset of prion disease for the HY strain of transmissible mink encephalopathy as a result of prior peripheral inoculation with the replication-deficient DY strain
J. Gen. Virol., January 1, 2004; 85(1): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Aucouturier and C. Carnaud
The immune system and prion diseases: a relationship of complicity and blindness
J. Leukoc. Biol., December 1, 2002; 72(6): 1075 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. M. Luhr, R. P. A. Wallin, H.-G. Ljunggren, P. Low, A. Taraboulos, and K. Kristensson
Processing and Degradation of Exogenous Prion Protein by CD11c+ Myeloid Dendritic Cells In Vitro
J. Virol., October 25, 2002; 76(23): 12259 - 12264.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
H. Narang
A Critical Review of the Nature of the Spongiform Encephalopathy Agent: Protein Theory Versus Virus Theory
Experimental Biology and Medicine, January 1, 2002; 227(1): 4 - 19.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Wisniewski, M. Bruce, and H Fraser
Infectious etiology of neuritic (senile) plaques in mice
Science, December 12, 1975; 190(4219): 1108 - 1110.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.